<p>While at least five pharmaceutical companies of India are engaged in vaccine development, Serum Institute in Pune has been chosen for mass production of Covishield vaccine developed by Oxford–Astra Zeneca.&nbsp;<br />
&nbsp;</p>

<p>The vaccine manufacturer has completed phase-3 human trials, with the Serum Institute of India announcing last week that the Covishield vaccine is "safe and immunogenic".</p>
